An observational study at Karolinska Institutet shows that babies suffering oxygen-deficiency complications at birth are almost twice as likely to develop cardiovascular disease during childhood and early adulthood as those without such complications. Still, the absolute risk of cardiovascular disease is very low in young age. The findings are published in the journal The Lancet Regional Health – Europe.
According to the researchers, the study could be the first of its kind to examine how complications related to asphyxiation at birth – something that occurs in about four million babies a year globally – affects the risk of cardiovascular disease later in life. Previous research has mostly concentrated on the association between asphyxia in the neonatal period and brain development.
Despite the relatively high risk, the absolute number of babies who suffer from cardiovascular disease despite asphyxiation at birth is very low. After the 30-year follow-up period, only 0.3 percent of those with asphyxia-related complications had a cardiovascular diagnosis, compared with 0.15 percent of those without complications.
Since the study was observational, the researchers are unable to establish any causality or propose any underlying mechanisms.
Largest risk increase for stroke and heart failure
Neda Razaz.
Photo: Stefan Zimmerman.
The study followed over 2.8 million individuals born in Sweden between 1988 and 2018, of whom 31,419 suffered asphyxia-related complications at birth. A total of 4,165 cases of cardiovascular disease were identified during the follow-up period. The increase in risk was particularly salient for stroke and heart failure, as well as for atrial fibrillation. The researchers took into account potential confounders such as birth weight and maternal lifestyle.
“Even if the absolute risk of cardiovascular disease is low at a young age, our study shows that asphyxia-related complications at birth are associated with a higher risk of cardiovascular disease later in life,” says the study’s corresponding author , assistant professor at the , Karolinska Institutet.
Publication
“,” Neda Razaz, Mikael Norman, Tobias Alfvén, Sven Cnattingius, The Lancet Regional Health – Europe, online Nov. 3, 2022, doi: 10.1016/j.lanepe.2022.100532
